Consorci Hospitalari Parc Tauli

Site:	Consorci Hospitalari Parc Tauli
Address:
City:	Barcelona
State:
Zip:	08208
Country:	Spain

Phase	Trial	Trial Status	Site Status [desc]	Drug	NCT#
3	Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)	Completed	Active	Nilotinib or Imatinib	NCT00785785